Faithward Advisors, LLC

Position in MRK — Merck & Co., Inc.

CIK 1695078 LANCASTER, PA

Position in MRK

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,201,860

+$44,310 QoQ

Shares Held

9,353

-2.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#1,965

of 3,769 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Faithward Advisors, LLC holds $6,902,856 across 7 Drug Manufacturers - General names. MRK ranks #3 (17.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	7,824	$1,987,061
2	ABBV	AbbVie Inc.	6,192	$1,558,154
3	MRK	Merck & Co., Inc. This page	9,353	$1,201,860
4	LLY	ELI LILLY & Co	862	$1,033,908
5	AMGN	Amgen Inc	1,269	$459,530
6	GILD	Gilead Sciences, Inc.	3,229	$407,951
7	BMY	Bristol Myers Squibb Co	4,415	$254,392

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,201,860	9,353	-2.8%	Shares	Sole	2026-08-12
2026-03-31	$1,157,550	9,623	+33.8%	Shares	Sole	2026-04-17
2025-12-31	$757,135	7,193	-5.3%	Shares	Sole	2026-02-17
2025-09-30	$637,784	7,599	-3.9%	Shares	Sole	2025-11-19
2025-06-30	$626,234	7,911	-12.8%	Shares	Sole	2025-08-14
2025-03-31	$814,482	9,074	+3.2%	Shares	Sole	2025-05-16
2024-12-31	$875,026	8,796	-9.2%	Shares	Sole	2025-02-13
2024-09-30	$1,099,828	9,685	-6.7%	Shares	Sole	2024-11-14
2024-06-30	$1,285,415	10,383	+2.4%	Shares	Sole	2024-08-14
2024-03-31	$1,338,236	10,142	+83.3%	Shares	Sole	2024-05-15
2023-12-31	$603,098	5,532	+22.6%	Shares	Sole	2024-02-15
2023-09-30	$464,613	4,513	+3.0%	Shares	Sole	2023-11-15
2023-06-30	$505,522	4,381	+93.9%	Shares	Sole	2023-08-15
2023-03-31	$240,335	2,259	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.